Amedeo Smart

Free Medical Literature Service




  Free Subscription


1 Am J Med
2 Antimicrob Agents Chemother
1 Arch Virol
3 Biochem Biophys Res Commun
1 BMC Pediatr
1 Drug Saf
2 Drugs
4 Epidemiol Infect
7 J Clin Microbiol
1 J Exp Med
1 J Immunol
4 Lancet
3 MMWR Morb Mortal Wkly Rep
6 N Engl J Med
1 Pediatr Rev
3 PLoS Med
35 PLoS One
8 Proc Natl Acad Sci U S A
8 Vaccine

    Am J Med

  1. LIST JM, Long TG
    Community-Based Primary Care Management of 'Long COVID': A Center of Excellence Model at NYC Health+Hospitals.
    Am J Med. 2021;134:1232-1235.
    >> Share

    Antimicrob Agents Chemother

  2. BAGHDADI JD, Coffey KC, Adediran T, Goodman KE, et al
    Antibiotic Use and Bacterial Infection among Inpatients in the First Wave of COVID-19: a Retrospective Cohort Study of 64,691 Patients.
    Antimicrob Agents Chemother. 2021;65:e0134121.
    >> Share

  3. LI Y, Qi L, Bai H, Sun C, et al
    Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Monoclonal Antibody (SCTA01) Targeting SARS-CoV-2 in Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, Phase I Study.
    Antimicrob Agents Chemother. 2021;65:e0106321.
    >> Share

    Arch Virol

  4. JANG Y, Seo SH
    H5 cleavage-site peptide vaccine protects chickens from lethal infection by highly pathogenic H5 avian influenza viruses.
    Arch Virol. 2021 Oct 25. pii: 10.1007/s00705-021-05284.
    >> Share

    Biochem Biophys Res Commun

  5. RYU DK, Kang B, Noh H, Woo SJ, et al
    The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2.
    Biochem Biophys Res Commun. 2021;578:91-96.
    >> Share

  6. ZHENG L, Ma Y, Chen M, Wu G, et al
    SARS-CoV-2 spike protein receptor-binding domain N-glycans facilitate viral internalization in respiratory epithelial cells.
    Biochem Biophys Res Commun. 2021;579:69-75.
    >> Share

  7. VICTOR J, Deutsch J, Whitaker A, Lamkin EN, et al
    SARS-CoV-2 triggers DNA damage response in Vero E6 cells.
    Biochem Biophys Res Commun. 2021;579:141-145.
    >> Share

    BMC Pediatr

  8. BARRON D, Richards O, Archer F, Abdelrazek M, et al
    A cluster of children with facial nerve palsy in a high prevalence area for COVID-19.
    BMC Pediatr. 2021;21:470.
    >> Share


  9. ABBAS-HANIF A, Modi N, Smith SK, Majeed A, et al
    Covid-19 treatments and vaccines must be evaluated in pregnancy.
    BMJ. 2021;375:n2377.
    >> Share

  10. SHOLZBERG M, Tang GH, Rahhal H, AlHamzah M, et al
    Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial.
    BMJ. 2021;375:n2400.
    >> Share

  11. GURDASANI D, McKee M
    The parliamentary committee report on covid-19 response.
    BMJ. 2021;375:n2530.
    >> Share

  12. SHEATHER J, Slattery D
    The great resignation-how do we support and retain staff already stretched to their limit?
    BMJ. 2021;375:n2533.
    >> Share

  13. KOTTA PA, Elango M
    A guide for final year medical students: transitioning to foundation training during the covid-19 pandemic.
    BMJ. 2021;375:n2287.
    >> Share

  14. CRAWFORD SM, Edwards H, Zoltowski A
    England's stalled cancer progress: the enduring effect of the covid-19 pandemic.
    BMJ. 2021;375:n2549.
    >> Share

    The UK government's covid complacency shows lessons haven't been learned.
    BMJ. 2021;375:n2584.
    >> Share

    Drug Saf

  16. SALAMANCA DE LA CUEVA I, Cinconze E, Eckermann T, Nwoji U, et al
    Safety Profile of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season.
    Drug Saf. 2021 Oct 25. pii: 10.1007/s40264-021-01121.
    >> Share


  17. AHMED N, Pezacki JP
    Reply to Zhang and Zhu "MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19".
    Drugs. 2021;81:1693-1695.
    >> Share

  18. ZHANG S, Zhu F
    Comment on: "MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19".
    Drugs. 2021;81:1691-1692.
    >> Share

    Epidemiol Infect

  19. SINGH C, Naik BN, Pandey S, Biswas B, et al
    Effectiveness of COVID-19 vaccine in preventing infection and disease severity: a case-control study from an Eastern State of India.
    Epidemiol Infect. 2021;149:e224.
    >> Share

  20. AEMRO A, Amare NS, Shetie B, Chekol B, et al
    Determinants of COVID-19 vaccine hesitancy among health care workers in Amhara region referral hospitals, Northwest Ethiopia: a cross-sectional study.
    Epidemiol Infect. 2021;149:e225.
    >> Share

  21. MELOTTI R, Scaggiante F, Falciani M, Weichenberger CX, et al
    Prevalence and determinants of serum antibodies to SARS-CoV-2 in the general population of the Gardena valley.
    Epidemiol Infect. 2021;149:e194.
    >> Share

  22. CARLTON LH, Chen T, Whitcombe AL, McGregor R, et al
    Charting elimination in the pandemic: a SARS-CoV-2 serosurvey of blood donors in New Zealand.
    Epidemiol Infect. 2021;149:e173.
    >> Share

    J Clin Microbiol

  23. KERSH EN, Shukla M, Raphael BH, Habel M, et al
    At-Home Specimen Self-Collection and Self-Testing for Sexually Transmitted Infection Screening Demand Accelerated by the COVID-19 Pandemic: a Review of Laboratory Implementation Issues.
    J Clin Microbiol. 2021;59:e0264620.
    >> Share

  24. KANJI JN, Proctor DT, Stokes W, Berenger BM, et al
    Multicenter Postimplementation Assessment of the Positive Predictive Value of SARS-CoV-2 Antigen-Based Point-of-Care Tests Used for Screening of Asymptomatic Continuing Care Staff.
    J Clin Microbiol. 2021;59:e0141121.
    >> Share

    Can Testing Predict SARS-CoV-2 Infectivity? The Potential for Certain Methods To Be Surrogates for Replication-Competent Virus.
    J Clin Microbiol. 2021;59:e0046921.
    >> Share

  26. LAM C, Gray K, Gall M, Sadsad R, et al
    SARS-CoV-2 Genome Sequencing Methods Differ in Their Abilities To Detect Variants from Low-Viral-Load Samples.
    J Clin Microbiol. 2021;59:e0104621.
    >> Share

  27. PEGHIN M, De Martino M, Fabris M, Palese A, et al
    The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after Recovery.
    J Clin Microbiol. 2021;59:e0113821.
    >> Share

  28. TCHESNOKOVA V, Kulasekara H, Larson L, Bowers V, et al
    Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants.
    J Clin Microbiol. 2021;59:e0092121.
    >> Share

  29. SEXTON ME, Kraft CS
    Routine Antigen Testing Is Not a Substitute for Health Care Worker Vaccination against SARS-CoV-2.
    J Clin Microbiol. 2021;59:e0156421.
    >> Share

    J Exp Med

  30. LU X, Hosono Y, Nagae M, Ishizuka S, et al
    Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients.
    J Exp Med. 2021;218.
    >> Share

    J Immunol

  31. SCOTT J, Ruchaud-Sparagano MH, Musgrave K, Roy AI, et al
    Phosphoinositide 3-Kinase delta Inhibition Improves Neutrophil Bacterial Killing in Critically Ill Patients at High Risk of Infection.
    J Immunol. 2021;207:1776-1784.
    >> Share


  32. VASAN A, Kenyon CC, Roberto CA, Fiks AG, et al
    Association of Remote vs In-Person Benefit Delivery With WIC Participation During the COVID-19 Pandemic.
    JAMA. 2021 Aug 20. pii: 2783501. doi: 10.1001/jama.2021.14356.
    >> Share

  33. STEENSELS D, Pierlet N, Penders J, Mesotten D, et al
    Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.
    JAMA. 2021 Aug 30. pii: 2783797. doi: 10.1001/jama.2021.15125.
    >> Share

  34. COFFEY KC, Diekema DJ, Morgan DJ
    Interpreting SARS-CoV-2 Test Results.
    JAMA. 2021 Sep 17. pii: 2784473. doi: 10.1001/jama.2021.16146.
    >> Share

  35. ABBASI J
    Moderna's mRNA Vaccine for Seasonal Flu Enters Clinical Trials.
    JAMA. 2021;326:1365.
    >> Share

  36. PEREZ A
    The Other Side.
    JAMA. 2021;326:1479-1480.
    >> Share


  37. SAAG MS
    Developing COVID-19 vaccine policy in increments.
    Lancet. 2021;398:1382-1383.
    >> Share

  38. PRENDECKI M, Thomson T, Clarke CL, Martin P, et al
    Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients.
    Lancet. 2021 Oct 4. pii: S0140-6736(21)02096.
    >> Share

  39. VAN HELDEN J, Butler CD, Achaz G, Canard B, et al
    An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2.
    Lancet. 2021 Sep 17. pii: S0140-6736(21)02019.
    >> Share

  40. KEUSCH GT, Lam SK, Mackenzie JS, Saif L, et al
    An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2 - Authors' reply.
    Lancet. 2021 Sep 17. pii: S0140-6736(21)02013.
    >> Share

    MMWR Morb Mortal Wkly Rep

  41. TAYLOR CA, Patel K, Pham H, Whitaker M, et al
    Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance - COVID-NET, 14 States, January-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1513-1519.
    >> Share

  42. OLSON SM, Newhams MM, Halasa NB, Price AM, et al
    Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1483-1488.
    >> Share

  43. XU S, Huang R, Sy LS, Glenn SC, et al
    COVID-19 Vaccination and Non-COVID-19 Mortality Risk - Seven Integrated Health Care Organizations, United States, December 14, 2020-July 31, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1520-1524.
    >> Share

    N Engl J Med

  44. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New Look at Covid-19 Vaccine Boosters.
    N Engl J Med. 2021;385:e72.
    >> Share

  45. BALSARI S, Kiang MV, Buckee CO
    Data in Crisis - Rethinking Disaster Preparedness in the United States.
    N Engl J Med. 2021;385:1526-1530.
    >> Share

    Peak Moments - When Kindergarten Is High Risk.
    N Engl J Med. 2021;385:1543-1545.
    >> Share

  47. FALSEY AR, Frenck RW Jr, Walsh EE, Kitchin N, et al
    SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.
    N Engl J Med. 2021 Sep 15. doi: 10.1056/NEJMc2113468.
    >> Share

  48. HOCK H, Kelly HR, Meyerowitz EA, Frigault MJ, et al
    Case 31-2021: A 21-Year-Old Man with Sore Throat, Epistaxis, and Oropharyngeal Petechiae.
    N Engl J Med. 2021;385:1511-1520.
    >> Share

  49. RUBIN EJ, Baden LR, Wu KJ, Morrissey S, et al
    Audio Interview: Reporting on Covid-19.
    N Engl J Med. 2021;385:e66.
    >> Share

    Pediatr Rev

  50. SHUST GF, Soma VL, Kahn P, Ratner AJ, et al
    Multisystem Inflammatory Syndrome in Children.
    Pediatr Rev. 2021;42:399-401.
    >> Share

    PLoS Med

  51. BERGQVIST R, Ahlqvist VH, Lundberg M, Hergens MP, et al
    HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study.
    PLoS Med. 2021;18:e1003820.
    >> Share

  52. GILBODY S, Littlewood E, McMillan D, Chew-Graham CA, et al
    Behavioural activation to prevent depression and loneliness among socially isolated older people with long-term conditions: The BASIL COVID-19 pilot randomised controlled trial.
    PLoS Med. 2021;18:e1003779.
    >> Share

  53. MO Y, Eyre DW, Lumley SF, Walker TM, et al
    Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort study.
    PLoS Med. 2021;18:e1003816.
    >> Share

    PLoS One

  54. SAVIKANGAS T, Tormakangas T, Tirkkonen A, Alen M, et al
    The effects of a physical and cognitive training intervention vs. physical training alone on older adults' physical activity: A randomized controlled trial with extended follow-up during COVID-19.
    PLoS One. 2021;16:e0258559.
    >> Share

  55. PHILLIPS R, Taiyari K, Torrens-Burton A, Cannings-John R, et al
    Cohort profile: The UK COVID-19 Public Experiences (COPE) prospective longitudinal mixed-methods study of health and well-being during the SARSCoV2 coronavirus pandemic.
    PLoS One. 2021;16:e0258484.
    >> Share

  56. ILIC J, Radovic K, Savic-Stankovic T, Popovac A, et al
    The effect of COVID-19 pandemic on final year dental students' self-confidence level in performing clinical procedures.
    PLoS One. 2021;16:e0257359.
    >> Share

  57. BONANOMI A, Facchin F, Barello S, Villani D, et al
    Prevalence and health correlates of Onine Fatigue: A cross-sectional study on the Italian academic community during the COVID-19 pandemic.
    PLoS One. 2021;16:e0255181.
    >> Share

  58. BALTAZAR LR, Manzanillo MG, Gaudillo J, Viray ED, et al
    Artificial intelligence on COVID-19 pneumonia detection using chest xray images.
    PLoS One. 2021;16:e0257884.
    >> Share

  59. ZAGIDULLIN NS, Motloch LJ, Musin TI, Bagmanova ZA, et al
    J-waves in acute COVID-19: A novel disease characteristic and predictor of mortality?
    PLoS One. 2021;16:e0257982.
    >> Share

  60. D'HAESE PF, Finomore V, Lesnik D, Kornhauser L, et al
    Prediction of viral symptoms using wearable technology and artificial intelligence: A pilot study in healthcare workers.
    PLoS One. 2021;16:e0257997.
    >> Share

  61. KINTZIGER KW, Stone KW, Jagger MA, Horney JA, et al
    The impact of the COVID-19 response on the provision of other public health services in the U.S.: A cross sectional study.
    PLoS One. 2021;16:e0255844.
    >> Share

  62. MILLAR JA, Dao HDN, Stefopulos ME, Estevam CG, et al
    Risk factors for increased COVID-19 case-fatality in the United States: A county-level analysis during the first wave.
    PLoS One. 2021;16:e0258308.
    >> Share

  63. GIESBRECHT E, Faieta J, Best K, Routhier F, et al
    Impact of the TEAM Wheels eHealth manual wheelchair training program: Study protocol for a randomized controlled trial.
    PLoS One. 2021;16:e0258509.
    >> Share

  64. LOPES AR, Nihei OK
    Depression, anxiety and stress symptoms in Brazilian university students during the COVID-19 pandemic: Predictors and association with life satisfaction, psychological well-being and coping strategies.
    PLoS One. 2021;16:e0258493.
    >> Share

  65. MAISON D, Jaworska D, Adamczyk D, Affeltowicz D, et al
    The challenges arising from the COVID-19 pandemic and the way people deal with them. A qualitative longitudinal study.
    PLoS One. 2021;16:e0258133.
    >> Share

  66. VENETI L, Seppala E, Larsdatter Storm M, Valcarcel Salamanca B, et al
    Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 -May 2021.
    PLoS One. 2021;16:e0258513.
    >> Share

  67. HORI H, Fukuchi T, Sanui M, Moriya T, et al
    Comprehensive infection control measures prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection: A single-center prospective cohort study and seroprevalence survey.
    PLoS One. 2021;16:e0257513.
    >> Share

  68. LUO W, Guo W, Hu S, Yang M, et al
    Flatten the curve: Empirical evidence on how non-pharmaceutical interventions substituted pharmaceutical treatments during COVID-19 pandemic.
    PLoS One. 2021;16:e0258379.
    >> Share

  69. BOKEMPER SE, Cucciniello M, Rotesi T, Pin P, et al
    Experimental evidence that changing beliefs about mask efficacy and social norms increase mask wearing for COVID-19 risk reduction: Results from the United States and Italy.
    PLoS One. 2021;16:e0258282.
    >> Share

  70. LAUNAY T, Souty C, Vilcu AM, Turbelin C, et al
    Common communicable diseases in the general population in France during the COVID-19 pandemic.
    PLoS One. 2021;16:e0258391.
    >> Share

  71. BUCHANAN K, Aknin LB, Lotun S, Sandstrom GM, et al
    Brief exposure to social media during the COVID-19 pandemic: Doom-scrolling has negative emotional consequences, but kindness-scrolling does not.
    PLoS One. 2021;16:e0257728.
    >> Share

  72. SJOGREN L, Stenberg E, Thuccani M, Martikainen J, et al
    Impact of obesity on intensive care outcomes in patients with COVID-19 in Sweden-A cohort study.
    PLoS One. 2021;16:e0257891.
    >> Share

  73. ALOTHMAN SA, Alghannam AF, Almasud AA, Altalhi AS, et al
    Lifestyle behaviors trend and their relationship with fear level of COVID-19: Cross-sectional study in Saudi Arabia.
    PLoS One. 2021;16:e0257904.
    >> Share

  74. JACOBS J, Johnson AK, Boshara A, Hunt B, et al
    COVID-19 health inequities and association with mechanical ventilation and prolonged length of stay at an urban safety-net health system in Chicago.
    PLoS One. 2021;16:e0258243.
    >> Share

  75. MCKENNA-PLUMLEY PE, Graham-Wisener L, Berry E, Groarke JM, et al
    Connection, constraint, and coping: A qualitative study of experiences of loneliness during the COVID-19 lockdown in the UK.
    PLoS One. 2021;16:e0258344.
    >> Share

  76. HAWLADER MDH, Rashid MU, Khan MAS, Ara T, et al
    Quality of life of COVID-19 recovered patients in Bangladesh.
    PLoS One. 2021;16:e0257421.
    >> Share

  77. GHOSHAL U, Garg A, Vasanth S, Arya AK, et al
    Assessing a chip based rapid RTPCR test for SARS CoV-2 detection (TrueNat assay): A diagnostic accuracy study.
    PLoS One. 2021;16:e0257834.
    >> Share

  78. CHING SM, Ng KY, Lee KW, Yee A, et al
    Psychological distress among healthcare providers during COVID-19 in Asia: Systematic review and meta-analysis.
    PLoS One. 2021;16:e0257983.
    >> Share

  79. TRAKARNVANICH T, Phumisantiphong U, Pupipatpab S, Setthabramote C, et al
    Impact of ultraviolet germicidal irradiation on new silicone half-piece elastometric respirator (VJR-NMU) performance, structural integrity and sterility during the COVID-19 pandemic.
    PLoS One. 2021;16:e0258245.
    >> Share

  80. BARBERO J, de Lucio JJ, Rodriguez-Crespo E
    Effects of COVID-19 on trade flows: Measuring their impact through government policy responses.
    PLoS One. 2021;16:e0258356.
    >> Share

  81. ORR-BURKS N, Murray J, Todd KV, Bakre A, et al
    Drug repositioning of Clopidogrel or Triamterene to inhibit influenza virus replication in vitro.
    PLoS One. 2021;16:e0259129.
    >> Share

  82. JANG H, Ross TM
    Influence of the H1N1 influenza pandemic on the humoral immune response to seasonal flu vaccines.
    PLoS One. 2021;16:e0258453.
    >> Share

  83. CHOW EJ, Tenforde MW, Rolfes MA, Lee B, et al
    Differentiating severe and non-severe lower respiratory tract illness in patients hospitalized with influenza: Development of the Influenza Disease Evaluation and Assessment of Severity (IDEAS) scale.
    PLoS One. 2021;16:e0258482.
    >> Share

  84. CHOW YP, Chin BHZ, Loo JM, Moorthy LR, et al
    Clinical and epidemiological characteristics of patients seeking COVID-19 testing in a private centre in Malaysia: Is there a role for private healthcare in battling the outbreak?
    PLoS One. 2021;16:e0258671.
    >> Share

  85. KAPETANOS K, Mazeri S, Constantinou D, Vavlitou A, et al
    Exploring the factors associated with the mental health of frontline healthcare workers during the COVID-19 pandemic in Cyprus.
    PLoS One. 2021;16:e0258475.
    >> Share

  86. SHICHIJO K, Takeuchi S, Tayama T, Takei M, et al
    Patient attendance at a pediatric emergency referral hospital in an area with low COVID-19 incidence.
    PLoS One. 2021;16:e0258478.
    >> Share

  87. PHUONG J, Hyland SL, Mooney SJ, Long DR, et al
    Sociodemographic and clinical features predictive of SARS-CoV-2 test positivity across healthcare visit-types.
    PLoS One. 2021;16:e0258339.
    >> Share

  88. PECKHAM E, Allgar V, Crosland S, Heron P, et al
    Health risk behaviours among people with severe mental ill health during the COVID-19 pandemic: Analysis of linked cohort data.
    PLoS One. 2021;16:e0258349.
    >> Share

    Proc Natl Acad Sci U S A

  89. WU X, Rapoport TA
    Cryo-EM structure determination of small proteins by nanobody-binding scaffolds (Legobodies).
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  90. URANO E, Okamura T, Ono C, Ueno S, et al
    COVID-19 cynomolgus macaque model reflecting human COVID-19 pathological conditions.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  91. CHERNOZHUKOV V, Kasahara H, Schrimpf P
    The association of opening K-12 schools with the spread of COVID-19 in the United States: County-level panel data analysis.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  92. POULTER B, Freeborn PH, Jolly WM, Varner JM, et al
    COVID-19 lockdowns drive decline in active fires in southeastern United States.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  93. HUGHES MT, Auwaerter PG, Ehmann MR, Garibaldi BT, et al
    Opinion: The importance of offering vaccine choice in the fight against COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  94. XIA D, Jin R, Byagathvalli G, Yu H, et al
    An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  95. PISHESHA N, Harmand TJ, Rothlauf PW, Praest P, et al
    A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  96. LU L, Anderson B, Ha R, D'Agostino A, et al
    A language-matching model to improve equity and efficiency of COVID-19 contact tracing.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share


  97. LOEB M, Russell ML, Kelly-Stradiotto C, Fuller N, et al
    Adjuvanted trivalent influenza vaccine versus quadrivalent inactivated influenza vaccine in Hutterite Children: A randomized clinical trial.
    Vaccine. 2021 Oct 23. pii: S0264-410X(21)01355.
    >> Share

  98. CORCORAN KE, Scheitle CP, DiGregorio BD
    Christian nationalism and COVID-19 vaccine hesitancy and uptake.
    Vaccine. 2021 Oct 2. pii: S0264-410X(21)01289.
    >> Share

  99. MOSINA L, Kulper-Schiek W, Jacques-Carroll L, Earnshaw A, et al
    Supporting National Immunization Technical Advisory Groups in the WHO European Region in developing national COVID-19 vaccination recommendations through online communication platform.
    Vaccine. 2021 Sep 16. pii: S0264-410X(21)01225.
    >> Share

  100. FISHER KA, Nguyen N, Crawford S, Fouayzi H, et al
    Preferences for COVID-19 vaccination information and location: Associations with vaccine hesitancy, race and ethnicity.
    Vaccine. 2021 Sep 25. pii: S0264-410X(21)01261.
    >> Share

  101. ALLEVA DG, Delpero AR, Scully MM, Murikipudi S, et al
    Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452.
    Vaccine. 2021 Oct 5. pii: S0264-410X(21)01294.
    >> Share

  102. DANG TKNS, Rivero Cabrera R, Yeung KHT, van der Putten IM, et al
    Feasibility of age- and gestation-based routine universal influenza vaccines schedules for children aged 6 months - 2 years and pregnant women.
    Vaccine. 2021 Oct 18. pii: S0264-410X(21)01291.
    >> Share

  103. CHANTHAVANICH P, Versage E, Van Twuijver E, Hohenboken M, et al
    Antibody responses against heterologous A/H5N1 strains for an MF59-adjuvanted cell culture-derived A/H5N1 (aH5N1c) influenza vaccine in healthy pediatric subjects.
    Vaccine. 2021 Oct 25. pii: S0264-410X(21)01317.
    >> Share

  104. LAZAROS G, Anastassopoulou C, Hatziantoniou S, Kalos T, et al
    A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States.
    Vaccine. 2021 Oct 5. pii: S0264-410X(21)01295.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016